RICHMOND, Va., Oct. 18, 2017 -- Kinsale Capital Group, Inc. (NASDAQ:KNSL) announced today that it will release financial results for the third quarter of 2017 after the market closes on Thursday, November 2, 2017.
The Company will host a conference call to discuss its results with analysts and investors on Friday, November 3, 2017, beginning at 9:00 a.m. (Eastern Time). The release will also be available on the Company’s website, www.kinsalecapitalgroup.com.
To access the conference call, dial (844) 239-5282, conference ID# 96128388, or via the Internet by going to www.kinsalecapitalgroup.com and clicking on the “Investor Relations” link. Please visit the website at least 15 minutes before the call to register and download and install any necessary audio software. A replay of the call will be available on the website until the close of business on January 3, 2018.
About Kinsale Capital Group
Kinsale Capital Group, Inc. is a specialty insurance group headquartered in Richmond, Virginia, focusing on the excess and surplus lines market.
For more information contact:
Kinsale Capital Group, Inc.
(804) 289-1272
[email protected]


Neuralink Plans Automated Brain Implant Surgeries and Mass Production by 2026
Samsung Signals Comeback With HBM4 Chips as AI Market Heats Up
Disney Agrees to $10 Million Settlement Over Child Privacy Violations on YouTube
Target Stock Rallies as Activist Interest Sparks Hopes for Strategic Change
Elon Musk’s xAI Expands Supercomputer Infrastructure With Third Data Center to Boost AI Training Power
Anghami Stock Soars After Strong H1 2025 Results, Revenue Nearly Doubles on OSN+ Integration
Vanda Pharmaceuticals Wins FDA Approval for New Motion Sickness Drug After Four Decades
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China as Competition Intensifies
Citigroup to Exit Russia With Sale of AO Citibank to Renaissance Capital
Applied Digital Stock Rises on AI Cloud Spinoff Plan and ChronoScale Launch
Australia’s Modern Gold Rush: Hobby Prospectors Flock to Victoria’s Golden Triangle
Hyundai Faces Deadline on Russia Plant Buyback Amid Ukraine War and Sanctions
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China, Boosting Access to Wegovy and Mounjaro
Google Accelerates AI Infrastructure With Ironwood TPU Expansion in 2026
SoftBank Completes $41 Billion OpenAI Investment in Historic AI Funding Round
Nike Stock Rises After CEO Elliott Hill Buys $1 Million in Shares
Royalty Pharma Stock Rises After Acquiring Full Evrysdi Royalty Rights from PTC Therapeutics 



